Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients. Issue 1 (22nd November 2020)

• Record Type: Journal Article
• Authors: Kurashige, Takashi; Takahashi, Tetsuya; Nagano, Yoshito; Sugie, Kazuma; Maruyama, Hirofumi
• Is Part Of: Neuropathology. Volume 41:Issue 1(2021)
• Page Start: 29
• Page End: 36
• Publication Date: 2020-11-22
• Subjects: GNE myopathy -- hyposialylation -- KL‐6 -- MUC1 -- rimmed vacuoles; Nervous system -- Diseases -- Periodicals; Nervous system -- Pathophysiology -- Periodicals; 616.8047
• DOI: 10.1111/neup.12703
• Languages: English
• ISSNs: 0919-6544

Abstract

Abstract : UDP‐ N ‐acetylglucosamine 2‐epimerase/ N ‐acetylmannosamine kinase (GNE) is necessary for sialic acid biosynthesis. GNE myopathy is caused by a defect in GNE, and hyposialylation is a key factor in the pathomechanism of GNE myopathy. Although candidates for evaluating hyposialylation have been reported, it is difficult to measure them in routine clinical practice. Sialylation is necessary for synthesis of various glycoproteins, including Krebs von den Lungen‐6 (KL‐6)/mucin 1 (MUC1). Here we report that KL‐6/MUC1 is decreased in GNE myopathy. We observed that KL‐6 levels were decreased in the serum of patients with GNE myopathy, and that KL‐6 and MUC1‐C were also decreased in muscle biopsy specimens from these patients. An immunofluorescent study revealed that KL‐6 and MUC1‐C were not present in the sarcolemma but were, instead, localized in rimmed vacuoles in specimens from patients with GNE myopathy. KL‐6 is already used to detect lung diseases in clinical practice, and this glycoprotein may be a novel candidate for evaluating hyposialylation in GNE myopathy.